@article{housseldebry:hal-01807755,
TITLE = {12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation},
AUTHOR = {Houssel-Debry, Pauline and Coilly, Audrey and Fougerou-Leurent, Claire and Jezequel, Caroline and Duvoux, Christophe and de Ledinghen, Victor and Radenne, Sylvie and Kamar, Nassim and Leroy, Vincent and Di Martino, Vincent and d'Alteroche, Louis and Canva, Val{\'e}rie and Conti, Filomena and Dumortier, Jerome and Montialoux, H{\'e}l{\`e}ne and Lebray, Pascal and Botta-Fridlund, Danielle and Tran, Albert and Moreno, Christophe and Silvain, Christine and Besch, Camille and Perre, Philippe and Francoz, Claire and Abergel, Armando and Habersetzer, Fran{\c c}ois and Debette-Gratien, Maryline and Cagnot, Carole and Diallo, Alpha and Chevaliez, St{\'e}phane and Rossignol, Emilie and Veislinger, Aurelie and Duclos-Vallee, Jean-Charles and Pageaux, Georges-Philippe},
URL = {https://univ-rennes.hal.science/hal-01807755},
JOURNAL = {Hepatology},
PUBLISHER = {Wiley-Blackwell},
VOLUME = {68},
NUMBER = {4},
PAGES = {1277-1287},
YEAR = {2018},
MONTH = Apr, DOI = {10.1002/hep.29918},
KEYWORDS = {Ribavirin use ; treatment duration ; ANRS CO23 CUPILT cohort ; Direct-acting antiviral agents},
HAL_ID = {hal-01807755},
HAL_VERSION = {v1},
}